The Division of Surgical Oncology and Endocrine Surgery is an integral part of the Vanderbilt Department of Surgery. Emphasis is placed on the evaluation and treatment of patients with benign and malignant tissue disorders. We use a multidisciplinary approach to patient care and work closely to coordinate our efforts with the Divisions of Radiation Oncology, Medical Oncology, Gynecologic Oncology, Hematology, and Surgical Pathology.

R. Daniel Beauchamp, MD:
TGF-beta and Ras signaling in colon cancer, mouse models of colon cancer.
Mark C. Kelley, MD:
Dendritic cell immunotherapy for melanoma, growth factor signaling and molecular targeted therapy for melanoma.

A. Scott Pearson, MD:
Regulation of cell adhesion and tight junctions in colon carcinogenesis.
Nipun Merchant, MD:
EGF signaling in colon cancer, molecular targeted therapy for colon cancer.
Ingrid Meszoely, MD:
DPC4 replacement gene therapy in pancreatic cancer.
James T. Broome, MD:
Intra-operative identification of thyroid and parathyroid tissue using optical fluorescence; surgical techniques in treatment of adrenal cortical carcinoma.
Ana Grau, MD:
TGF-beta and Ras signaling in breast cancer.
Eric H. Liu, MD:
Islet transplantation and imaging of the beta cell for diagnosis and treatment of diabetes; immunology and transplantation.